The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed.
Vesalius Biocapital offers venture capital to young European innovative life science companies.
Venture capital1445 Strassen, Luxembourgvesaliusbiocapital.comRounds from 2021-02-01 to 2026-10-06
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Rouge Therapeutics A provider of first-in-class disease-modifying therapies designed to restore vascular integrity | Series A Verified against 4 of 26 sources | $58M | 2026-10-06 | [ PART ] |
Sword Health Sword provides digital health solutions through its AI Care platform, supporting individuals with various healthcare needs such as musculoskeletal pain, women's health, and mental health services. | Series B |
| $25M |
| 2021-02-01 |
| [ PART ] |